Potential Drug Target or Biomarker AHI1-DT (G100131814)

Target Name: AHI1-DT

NCBI ID: G100131814

Potential Drug Target or Biomarker AHI1-DT

The AHI1-DT (AHI1 divergent transcript) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The AHI1 gene is located on chromosome 18q and encodes for a protein known as AHI1, which is involved in a variety of cellular processes including cell adhesion, migration, and survival. The AHI1-DT has been shown to play a crucial role in the regulation of these processes and is a promising target for therapeutic intervention.

Drug Target Potential

The AHI1-DT has been identified as a potential drug target due to its unique structure and function. The AHI1-DT is a non-coding RNA molecule that can interact with the protein AHI1, which is a seven-transmembrane protein involved in cell adhesion and migration. This interaction between the AHI1-DT and AHI1 suggests that the AHI1-DT may be a useful target for small molecule inhibitors that can modulate the activity of AHI1.

In addition to its potential as a drug target, the AHI1-DT has also been identified as a potential biomarker for a variety of diseases. The AHI1 gene is known to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The AHI1-DT has been shown to be expressed in a variety of tissues and conditions, including cancer cells, neurotransmitter-induced synaptic plasticity, and autoimmune mouse models.

Expression and Localization

The AHI1 gene is located on chromosome 18q and has been shown to encode for a protein that is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. The AHI1 protein is a seven-transmembrane protein that is involved in the regulation of adhesion molecule interactions, cytoskeletal organization, and survival signaling pathways. The AHI1-DT has been shown to be a stable RNA molecule that is expressed in various tissues and conditions, including cancer cells, neurotransmitter-induced synaptic plasticity, and autoimmune mouse models.

The localization of the AHI1-DT has been determined through a variety of techniques, including RNA sequencing, RNA immunoprecipitation, and in vitro transcription assays. These studies have shown that the AHI1-DT is expressed in various tissues and conditions, including cancer cells, neurotransmitter-induced synaptic plasticity, and autoimmune mouse models. The AHI1-DT has been shown to be expressed in the nuclei of these cells and to interact with the protein AHI1.

Function and Interaction

The AHI1-DT has been shown to play a crucial role in the regulation of various cellular processes, including cell adhesion, migration, and survival. One of the most significant functions of the AHI1-DT is its role in the regulation of cell adhesion. The AHI1-DT has been shown to be involved in the regulation of adhesion molecule interactions and to play a role in the formation of tight junctions, which are a type of cell-cell adhesion structure.

In addition to its role in cell adhesion, the AHI1-DT has also been shown to play a role in the regulation of cell migration. The AHI1-DT has been shown to be involved in the regulation of the migration of various cell types, including cancer cells, and to play a role in the regulation of cell migration in neurotransmitter-induced synaptic plasticity.

The AHI1-DT has also been shown to play a role in the regulation of

Protein Name: AHI1 Divergent Transcript

More Common Targets